PET/CT Scan

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

A Study of Imaging in Demyelinating Diseases

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Exploratory Evaluation of [11C]-NOP46

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)

Using Biomarkers to Predict TB Treatment Duration

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance

PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)

Evaluation of Splenic Metabolic Activity With 18FDG-PET in Hypertension

Siderophores for Imaging Infection Using 68Ga-DFO

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

68Ga-FAPI PET/CT in Patients With Various Types of Cancer